Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy

S. A. Wayangankar, M. T. Roe, A. Y. Chen, R. S. Gupta, R. P. Giugliano, L. K. Newby, James A de Lemos, K. P. Alexander, T. A. Sanborn, J. F. Saucedo

Research output: Contribution to journalArticle

Abstract

Objective: To analyze trends in utilization of anti-thrombotic agents (ATA) and in-hospital clinical outcomes in non-ST-elevation myocardial infarction (NSTEMI) patients managed with an invasive strategy from 2007 to 2010. Methods & results: Using ACTION Registry®-GWTG™ data, we analyzed trends in use of ATA and in-hospital clinical outcomes among 64,199 NSTEMI patients managed invasively between 2007 and 2010. ATA included unfractionated heparin (UFH), low molecular weight heparin (LMWH), glycoprotein IIb/IIIa inhibitors (GPI) and bivalirudin. Although the proportion of NSTEMI patients treated with PCI within 48h of hospital arrival was similar in 2007 and 2010, percentage use of bivalirudin (13.4-27.3%; p

Original languageEnglish (US)
JournalIndian Heart Journal
DOIs
StateAccepted/In press - Aug 3 2015

    Fingerprint

Keywords

  • Anti-thrombotic agents
  • Invasive strategy
  • Non-ST-segment elevation myocardial infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Wayangankar, S. A., Roe, M. T., Chen, A. Y., Gupta, R. S., Giugliano, R. P., Newby, L. K., de Lemos, J. A., Alexander, K. P., Sanborn, T. A., & Saucedo, J. F. (Accepted/In press). Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy. Indian Heart Journal. https://doi.org/10.1016/j.ihj.2015.09.036